Ankur Dhingra - Aug 16, 2022 Form 4/A - Amendment Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Financial Officer
Signature
/s/ Ankur Dhingra
Stock symbol
SMMT
Transactions as of
Aug 16, 2022
Transactions value $
$36,554
Form type
4/A - Amendment
Date filed
3/8/2023, 03:58 PM
Date Of Original Report
Aug 17, 2022
Previous filing
Jun 2, 2022
Next filing
Mar 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMMT Common Stock Purchase $12.6K +13K +49.16% $0.97 39.5K Aug 16, 2022 Direct F1
transaction SMMT Common Stock Purchase $23.9K +24.7K +182.14% $0.97 38.2K Aug 16, 2022 By Dhingra Family Revocable Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being amended to correct the number of shares purchased by the Reporting Person in the Issuer's rights offering. 1,470 shares were inadvertently omitted from the original filing.
F2 The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.